Advanced Search
Search
  
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
 

AMICAS Reports Financial Results for the First Quarter Ended March 31, 2009

Provides 2010 business outlook

BOSTON, May 11 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in medical image and information management solutions, today reported unaudited financial results for the first quarter ended March 31, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

Q1 Financial Highlights

Revenue: Total revenues for the first quarter of 2009 were $11.3 million compared to $12.8 million for the first quarter of 2008.

Operating Income/Loss: Operating loss for the first quarter of 2009 was $1.6 million compared to an operating loss of $1.2 million for the first quarter of 2008. Operating loss for the first quarter of 2009 included $549,000 of expenses related to the acquisition and integration of Emageon Inc.

Adjusted EBITDA: The Company's Adjusted EBITDA, excluding acquisition-related and integration costs for the first quarter of 2009, was $200,000 as compared to an Adjusted EBITDA of $33,000 for the first quarter of 2008.

Net Income/Loss: The Company's net loss for the first quarter of 2009 was $1.2 million, or $(0.03) per share, compared to net loss of $467,000, or $(0.01) per share, for the first quarter of 2008.

Cash and Cash Flow: AMICAS ended the first quarter of 2009 with cash, cash equivalents, and a marketable securities balance of $56.6 million, no long-term debt, and working capital of $47.7 million. AMICAS generated $1.8 million of cash flow from operations in the first quarter of 2009.

Stock Repurchase: In the fourth quarter of 2008, the Board of Directors directed the Company to initiate a $5.0 million stock repurchase plan. The Company repurchased approximately 88,000 shares of its common stock for approximately $141,000 in the first quarter of 2009. Under this plan, we have repurchased approximately 281,000 shares of our common stock for approximately $426,000.

Business Perspective

"The acquisition of Emageon clearly helps AMICAS scale to execute both as a top-flight IT solution provider and as a standalone independent public company. As a result of our combination with Emageon, AMICAS now provides a market leading suite that includes radiology PACS, radiology information systems, cardiology PACS, cardiovascular information systems, referring physician tools, business intelligence tools, enterprise content management tools (serving as both the imaging component of the EMR and as a vendor-neutral archive), and revenue cycle management systems," said Dr. Kahane.

Dr. Kahane also said, "We continue to maintain our focus on serving the end-to-end needs of imaging centers, radiology groups, and sub-specialty groups that are highly dependent on imaging during their delivery of healthcare services. At the same time, we are looking forward to providing the market with an enterprise content management solution that makes images accessible as a component of the electronic medical record."

Dr. Kahane went on to say, "We believe we have built an excellent foundation with many very sophisticated providers of imaging services while developing an excellent product suite over the last two years. We are looking forward to combining this foundation with the customers, solutions, and employees of Emageon to establish AMICAS as the premiere independent provider of image and information management solutions in healthcare."

Business Outlook

AMICAS expects to provide guidance for 2009 upon completion of its purchase accounting related to the Emageon Inc. acquisition, and to provide this guidance at the time that AMICAS releases its results for the second quarter of 2009.

Purchase accounting is expected to have minimal impact on 2010 results and, therefore, AMICAS is providing the following business outlook for fiscal year 2010.

  • Fiscal year 2010 revenue is expected to be $112 to $120 million
  • Fiscal year 2010 Adjusted EBITDA is expected to be $16.5 to $20.7 million

Conference Call

AMICAS will host a conference call on Tuesday, May 12, at 8:30 a.m. Eastern Time to discuss the Company's 2009 first fiscal quarter results. Investors and other interested parties may dial in to the call using the toll free number 1.800.862.9098. (Conference ID: 7AMICAS). The conference call will also be available via Webcast at www.amicas.com. Following the conclusion of the call, a replay will be available at 1.800.283.8520 or 402.220.0870 until June 12, 2009.

About AMICAS

AMICAS, Inc. (www.amicas.com) is a leading independent provider of imaging IT solutions. AMICAS offers the industry's most comprehensive suite of image and information management solutions - from radiology PACS to cardiology PACS, from radiology information systems to cardiovascular information systems, from revenue cycle management solutions to enterprise content management tools designed to power the imaging component of the electronic medical record. AMICAS provides a complete, end-to-end solution for radiology practices, imaging centers, and ambulatory care facilities. Hospitals and integrated delivery networks are provided with a comprehensive image management solution for cardiology and radiology that supports EMR strategies to enhance clinical, operational, and administrative functions.

Safe Harbor Statement

Except for the historical information herein, the matters discussed in this release include forward-looking statements. In particular, the forward-looking statements contained in this release include statements about our anticipated financial and operating results for the remainder of fiscal year 2009 and for fiscal year 2010. When used in this press release, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions, and uncertainties that could cause actual results to differ materially, which include, but are not limited to, the following: a significant portion of the Company's quarterly sales are concluded in the last month of the fiscal quarter; the length of sales and delivery cycles; the deferral and/or realization of deferred software license and system revenues according to contract terms; the timing, cost, and success or failure of current and new product and service introductions and product upgrade releases; potential patent infringement claims against AMICAS and the related defense costs; the ability of AMICAS to comply with all government laws, rules, and regulations; and other risks affecting AMICAS' businesses generally and as set forth in AMICAS' most recent filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" of our most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this release are qualified by these cautionary statements and are made only as of the date of this release. AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise. The financial statements and information as of, and for the period ended, March 31, 2009, contained in this press release are subject to review by the Company's independent registered public accounting firm.

Adjusted EBITDA Financial Measures

Adjusted EBITDA refers to net income (loss), adjusted for amortization, acquisition-related and integration costs, depreciation, interest, taxes, and stock compensation expense.

Management believes that its Adjusted EBITDA, when viewed in addition to the Company's reported GAAP results, provides an additional meaningful measure of operating performance, enabling investors to more thoroughly evaluate current performance in comparison to past performance. This information will necessarily differ from comparable information that may be provided by other companies and should not be considered in isolation or as an alternative to the Company's operating and other financial information determined under GAAP. A reconciliation of net income (loss) to Adjusted EBITDA is included below.

    CONTACT:
    Colleen McCormick, Investor Relations
    617.779.7892
    cmccormick@amicas.com
                    Condensed Consolidated Balance Sheets
                                (Unaudited)
                      (in thousands, except share data)



                                                  March 31,    December 31,
                                                      2009           2008
    Assets
    Current assets:
       Cash and cash equivalents                   $44,076         $7,366
       Marketable securities                        12,502         47,627
       Accounts receivable, net of allowances
        of $45 and $158, respectively                9,654         10,224
       Prepaid expenses and other current
        assets                                       2,671          2,261
    Total current assets                            68,903         67,478

    Property and equipment, less accumulated
     depreciation and amortization of $7,649 and
     $7,495, respectively                              863            965
    Acquired/developed software, less
     accumulated amortization of $10,766 and
     $10,195, respectively                           5,233          5,805
    Other intangible assets, less accumulated
     amortization of $676 and $2,144, respectively   1,224          1,256
    Other assets                                     1,747          1,594
    Total Assets                                   $77,970        $77,098

    Liabilities and stockholders' equity
    Current liabilities:
       Accounts payable and accrued expenses        $4,375         $4,156
       Accrued employee compensation and
        benefits                                     1,252          1,611
       Deferred revenue                             15,551         14,657
    Total current liabilities                       21,178         20,424

    Unrecognized tax benefits                        1,406          1,379
    Deferred revenue long term portion                 930              -

    Commitments and contingencies

    Stockholders' equity:
       Preferred stock $.001 par value;
        2,000,000 shares authorized; none issued         -              -
       Common stock $.001 par value, 200,000,000
        shares authorized, 51,558,435 and
        51,473,965 issued, respectively                 51             51
       Additional paid-in capital                  231,477        230,905
       Accumulated other comprehensive (loss)
        income                                          (2)           100
       Accumulated deficit                        (129,717)      (128,549)
       Treasury stock, at cost, 16,357,854 and
        16,270,088 shares                          (47,353)       (47,212)
    Total stockholders' equity                      54,456         55,295
    Total Liabilities and Stockholders' Equity     $77,970        $77,098



            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                             (Unaudited)
          (in thousands, except per share data and footnotes)

                                                      Three Months Ended
                                                           March 31,
                                                        2009        2008
    Revenues
      Maintenance and services                        $9,962      $9,753
      Software licenses and system sales               1,309       3,035
    Total revenues                                   $11,271      12,788

    Costs and expenses
    Cost of revenues:
      Maintenance and services (a)                    $4,232       4,269
      Software licenses and system sales,
       including amortization of software costs
       of $571 and $489, respectively                  1,060       2,211
    Selling, general and administrative (b)            4,521       5,002
    Research and development (c)                       2,286       2,195
    Depreciation and amortization                        185         275
    Acquisition-related and integration costs            549           -
                                                      12,833      13,952
    Operating loss                                    (1,562)     (1,164)
    Interest income                                      447         789
    Loss on sale of investments                            -         (31)
    Loss before provision for income taxes            (1,115)       (406)
    Provision for income taxes                            53          61
    Net loss                                         $(1,168)      $(467)


    (Loss) income per share
      Basic:                                          $(0.03)     $(0.01)
      Diluted:                                        $(0.03)     $(0.01)

    Weighted average number of shares outstanding
      Basic                                           35,195      43,628
      Diluted                                         35,195      43,628


    (a) includes $39,000 and $37,000 in stock-based compensation expense
        for the three months ended March 31, 2009, and 2008, respectively
    (b) includes $314,000 and $284,000 in stock-based compensation expense
        for the three months ended March 31, 2009, and 2008, respectively
    (c) includes $104,000 and $112,000 in stock-based compensation expense
        for the three months ended March 31, 2009, and 2008, respectively

              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                (Unaudited)
                               (in thousands)

                                                          Three Months Ended
                                                               March 31,
                                                           2009         2008
    Operating activities
    Net loss                                             (1,168)       $(467)

    Adjustments to reconcile net loss to cash
     provided by operating activities:
       Depreciation and amortization                        185          275
       Provisions for bad debts                             (73)          55
       Amortization of software development costs           571          489
       Non-cash stock compensation expense                  457          433
       Changes in operating assets and liabilities:
         Accounts receivable                                642         (489)
         Prepaid expenses and other current assets         (561)         532
         Accounts payable and accrued expenses             (140)        (306)
         Deferred revenue including unearned discount     1,824          454
         Unrecognized tax benefits                           27           25
           Cash provided by operating activities          1,764        1,001

    Investing activities
       Purchases of property and equipment                  (51)        (304)
       Purchases of held-to-maturity securities          (8,403)    (124,084)
       Maturities of held-to-maturity securities         27,595      113,799
       Purchases of available-for-sale securities       (20,363)      (1,500)
       Sales of available-for-sale securities            36,193       20,031
           Cash provided by investing activities         34,971        7,942

    Financing activities
       Repurchase of  common stock                         (141)      (4,593)
       Exercise of stock options                            116          181
           Cash used in financing activities                (25)      (4,412)

    Increase in cash and cash equivalents                36,710        4,531
    Cash and cash equivalents at beginning of period      7,366        8,536
    Cash and cash equivalents at end of period          $44,076      $13,067

    Supplemental disclosure of cash paid during the
     period for:
       Income taxes, net of refunds                          $-         $115
    Non-cash investing activity:
       Unrealized gain (loss) on available-for-sale
        securities                                        $(102)        $120



                     RECONCILIATION NET LOSS TO ADJUSTED EBITDA
                                   (Unaudited)
                                 (in thousands)

                                                    Three Months Ended
                                                        March 31,
                                                     2009       2008

      Net loss                                    $(1,168)     $(467)
      Provision for income taxes                       53         61
      Interest income                                 447        789
      Loss on sale of investments                       0        (31)
    Operating loss                                 (1,562)    (1,164)
      Non-cash stock compensation expense             457        433
      Acquisition-related and integration costs       549          -
      Depreciation and amortization                   185        275
      Amortization of software development costs      571        489
    Adjusted EBITDA                                  $200        $33



                         FISCAL YEAR 2010 BUSINESS OUTLOOK
                                  (in thousands)

                                                        FY 2010
                                                      Low       High
    Revenue                                      $112,000   $120,000
    Adjusted EBITDA                               $16,500    $20,700


                         FISCAL YEAR 2010 BUSINESS OUTLOOK
                  RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
                                 (in thousands)


                                                        FY 2010
                                                      Low       High
    Net income                                     $7,000    $11,000
      Provision for income taxes                      300        500
      Interest income                                 700        700
    Operating income                                6,600     10,800
      Non-cash stock compensation expense           2,500      2,500
      Depreciation and amortization                 7,400      7,400
    Adjusted EBITDA                               $16,500    $20,700


SOURCE AMICAS, Inc.